Plandai Biotechnology Inc (PLPL)

[BigBadWolf]

Control of the trash for all to see...& since I

why would I start now

[jimtash]

Fun fact. When posts were made stating that selling at .0006, taking your profits and rebuying in lower with money you could afford to lose is the best strategy, who was dumb enough to ignore it?

[Due Diligence Virtuoso]

Where did u learn how to value companies? My bullshit meter just went off. Please explain this calculation. I am always up for a laugh.

[Aquahoya]

Cool story bro.

[BigBadWolf]

My question is do any here believe in OTC Saviors or just another agenda driven l____r running their mouths while spewing mo’ chit after ….exiting & or looking for cheaper entry. Feel free to fill in the _____ w/ your choice of fitting thoughts.

[Nighthawk_1]

Never said that...LOL...But, people need to know ALL the information anyone may have that can enlighten them.😁 As I say in my book, "One learns from two types of people, those who do right and those who do wrong. Those who make right decisions and those who make wrong decisions. But, one needs to have all the information that is available in order to make the right decisions for themselve."

[Aquahoya]

I didn't know people in this room were forcing others to put cash into this stock, are they?

[Nighthawk_1]

Just making it real. I have my ways, others have theirs. You want to buy, go ahead, but don't expect me or others to follow suit.😁

[Aquahoya]

So, I imagine you are the noble night on 1000s of other OTC stocks telling people the exact same narrative, correct? You work must be very difficult with the 1000s upon 1000s of posts you must accumulate daily to tell people about the prospective of buying any OTC stock, right?

I mean, we are in the OTC. Everything is a gamble. What are you even talking about? You just make things up like "Whose line is it anyway?"

[Nighthawk_1]

Take the Market Cap and divide by A/S, that gives you the value of the stock. Now, naturally, the stock is higher if going by O/S, but, one has to realize that more shares will be sold.

[Nighthawk_1]

I'm just putting things in perspective to those who are thinking of buying here. I'm sure that no one wants to be stuck holding the bag.😅

[Due Diligence Virtuoso]

Not what some of the insiders said. Wonder why I pulled all my GTC Sells.. ROFL..

[zombywolf]

Then why bring it up when you have no clue?

[Nighthawk_1]

Restricted shares last only as long as one wants it to last.😅

[Aquahoya]

Thank you for sharing. Makes it even more interesting why you are wasting your time telling us this. Play another of the 10,000 stocks out there.

[zombywolf]

Then you are an idiot. There is a difference between restricted and unrestricted shares. And you have zero clue how long the restriction lasts.

[Nighthawk_1]

Based on my calculations, PLPL not even worth .0001

[Due Diligence Virtuoso]

Rick backed out cause FINRA would not approve a Reverse Split.. Please note how this current merger was constructed using an O/S adjustment over a RS.. Works better for retail shareholders IMO.. I suppose depending on the size and plans of the merging company, they might need to take corporate actions at a later date. They might have an uplist plan in place for Nasdaq.. So we shall see..

[Nighthawk_1]

I have dealt with restricted shares before.

[Nighthawk_1]

Does not matter...LOL...Outstanding shares include both Unrestricted and Restricted. Restricted is included as they can be sold, if those holding restricted shares pay a fee to sell them.

[zombywolf]

How many are restricted?

[Nighthawk_1]

Outstanding Shares: 44,000,000,000

[zombywolf]

That was the company that did extractions for cannabis a few years ago Sold the tech to TXTM. This has been an empty shell until now. Almost had a company here last year, but they backed out at the last minute. We are in better hands now I think.

[Jaxxm]

498 million bid x 15 million ask

[Due Diligence Virtuoso]

So SANJIAN CAPITAL is the translation. . This changes a lot of the facts to this merger, cause then San Global is not the English Translation, it is just a new fictitious name they made up. The holding company for the Merger is a "Capital Company"....

[Iwasbornpoor]

Try looking up the company again. It is not actively a company right now

[Iwasbornpoor]

Still going to wait till September ish. I d I not care about any news

[PoeseidonXXX]

Caren D Currier Presitent of PLPL He is also on the list of FCCC, Inc. (FCIC) As Accountant

(Former Chief Financial Officer, Fccc Inc, )

Caren has over 25 years of experience in accounting. Caren started her professional career helping her father with his construction company. While attending college, Caren was invited to intern with a CPA firm that had a number of construction firms as clients. This experience resulted in Caren's pursuit of a career in cost accounting. We are pleased that Caren has decided to continue on in this capacity with our management team.

[Builder1960]

Thank You

[bri123]

I think it translates to "Money" 😃

[Aquahoya]

I think it is the direct translation for the name "Sanjian".

[Due Diligence Virtuoso]

Found this. Perhaps relevant to the Import/Export registration, but who is Three Swords Capital Co, Ltd.?

[times3]

Yep, always paying attention

[Jaxxm]

.0005 is up

[Builder1960]

Thank you

[crazy horse 0]

Twitter 1,345 Followers


Plandai Biotech
@PlandaiBiotech
Plandai #Biotechnology Inc. is a company that specializes in highly bioavailable extracts from live plant materials. Unlocking #NaturesSecrets™ #health $PLPL
plandaibiotech.com
Joined February 2012
964 Following
1,345 Followers

https://twitter.com/PlandaiBiotech

https://twitter.com/PlandaiBiotech

[crazy horse 0]

Stickied your info Post stevc

Post 34036
Jaxxm, interesting X (Twitter) PLPL possible DD...

I have not made the time to verify any of this, but I had a friend of mine send me this as some interesting DD for PLPL to consider courtesy of Due Diligence Virtuoso, Aquahoya, and Masterpicks. It looks pretty good and is very interesting at the very least...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174280903

[Aquahoya]

https://twitter.com/PlandaiBiotech

[Builder1960]

Does PLPL have an X account? If so, can someone please share?

Thanking you in advance!

[times3]

It’s Monday for sure

[Jaxxm]

462 million bid x 16 million ask

[crazy horse 0]

Being Pink Current is an added Plus

Pink Open Market Logo
Pink Current Information
Verified Profile IconVerified Profile 02/2024
Transfer Agent Verified IconTransfer Agent Verified

https://www.otcmarkets.com/stock/PLPL/disclosure

[crazy horse 0]

Updates would be fantastic PLPL


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174281070

Jaxxm, with PLPL, something else very important to note...

We should be seeing some updates from the new company soon. There are lots of updates that have taken place on OTC Markets to include a "Change of Control" kicking in. The process for adding Officers and Directors to OTC Markets has changed. I suggest those not familiar with the process to call them and have them explain it to them. It is much more stringent than the days of old. You just can't simply go into the system and just start adding people to the profile of a company on OTC Markets during this new transition. There is "Background Check Paperwork" that is filled out to verify that the person is real and legit for being added. The Background Check is perform on that person with that person providing proof of their existence with providing a Drivers License, Passport, etc.

For PLPL to have all of those names added like they did on their OTC Markets Profile page, this leads me to think that they are much further along and much closer to launching their new direction than what some might realize in my opinion:
https://www.otcmarkets.com/stock/PLPL/profile

I would suspect that we should start seeing some news from the company soon elaborating a lot more on their new direction with their operations coming in here. At least that is what seems logical to me.

v/r
Sterling
Bullish
Bullish

Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.

[Aquahoya]

Thank you for the reply. That makes sense. I have had to call them on numerous issues but I never called them for this protocol. Honestly, I thought there was some verification process before the company would be given access to their profile.

Thanks,
Kevin

[stervc]

Aquahoya...

Over the years when you are wondering what's taking so long to get names up on OTC Markets with a stock, you simply call them and someone there will break you down on the process.

Also, I don't remember what company I called, but well over a year ago or so, a company's lawyer broke me down on how the process was too. Also, I'm sure any CEO or person you get within any company you would call and reach will explain this to you since they would be the ones going through it.

v/r
Sterling

[Aquahoya]

Hey Sterling,

Out of curiosity, how did you come to know the process. One would think they would have a detailed process involved now that does this to prove authenticity. Did you call them and ask these questions in the past?

Hopefully, we hear something soon.

Best,
Kevin

[times3]

Slow start this morning

[varok]

Good morning,

Let's keep the discussion for the current important phase on the R/M. We know the company announced through their quarterly period ending March 31, 2024, that they were no longer a shell company, as of the effective date of March 9, 2023.

This is the company's bio and very important as of the 1st quarter financial.

Current Operations Plandai Biotechnology, Inc. (“ PLPL ” or the “ Company “), a Nevada corporation, is a publicly quoted company. The Company's current operations are conducted at offices provided without charge in San Diego, California. PLPL does not have any ownership interest in the offices and there is no lease for the offices. The Company expects to utilize these offices indefinitely, pending the Company's possible merger with another entity. PLPL had previously owned intellectual properties related to its prior research, development and production of botanical extracts including, but not limited to: trademarks, trade secrets, and product formulations for green tea and citrus products from discontinued operations. The Company's intellectual properties were the result of research and development endeavors with North-West University in Potchefstroom, South Africa, and the Company's former Senteeko Tea Estate located in Mpumalanga, South Africa. The Company holds no current assets, and holds no other assets, as of December 31, 2023, and June 30, 2023. There was no revenue produced within the period, as entity was acting as a shell for the period. Expenses incurred in period were related to prorated accrued interest on convertible debt. A Supplemental Information Report was filed as of March 9, 2023, and discloses a change in the Shell Status of Plandai Biotechnology, Inc. ("Plandai"). Previously, Plandai disclosed that it was a shell company in its Alternative Reporting Disclosures with OTC Markets. As of the effective date of March 9, 2023, Plandai was no longer a shell company (see discussion below). By virtue of a Binding Memorandum of Understanding with Good Salt, LLC, a Florida limited liability company ("Good Salt") (included herewith as an exhibit), Plandai and Good Salt agreed to formalize a share exchange agreement whereby (i) Plandai would exchange restricted unregistered common shares, and separately, (ii) Plandai's majority shareholder would exchange Series "A" Preferred Common Stock with Good Salt, in exchange for (iii) all of the authorized and issued limited liability company interests of Good Salt. On August 1, 2023, there was a recission of the material definitive agreement with ByoPlant: The material definitive agreement, which was initially entered into on May 16, 2023, outlined the terms and conditions for the acquisition of the Company by Good Salt. However, despite diligent efforts and ongoing communications, conditions subsequent to the closing were unmet, and essential considerations were not settled. As a result, Plandai had no choice but to initiate the rescission process. The rescission will render the material definitive agreement null and void, and both parties will revert to their pre-agreement status. Gaelic for “plant food,” Plandaí historically engaged in the research and development of all-natural nutraceutical ingredients and unlocking their pharmaceutical potential. The Company invested in research and development and developed valuable intellectual property in delivery mechanisms for the delivery of therapeutic level of essential plantbased nutrients to human cells. The IP developed and owned by the Company includes targeted products that contain plant-curative properties.

The Company's proprietary trade secret extraction methods allow plant nutrients to be properly absorbed and remain in the system long enough for a therapeutic effect. The Company's technology restructures plant nutrients into a highly purified form that the body can more easily process while also increasing their absorption into the blood plasma and the length of time those nutrients remain present and active in your system. The Company produced and trademarked products associated with its extraction and delivery systems, including “Phytofare,” a product with all of the phytonutrients in a stable, highly bioavailable active extract. Business Plan PLPL has closed a transfer of control to San Global Dining Ltd and has changed management control. San Global Dining Ltd is a catering operation in Taiwan.

Corporate History: The Company was incorporated in the State of Nevada on February 24, 2004. PLPL has since remained incorporated in Nevada. The Company operated as a shell company up until March 9, 2023, when the Company changed to non-shell status via a pending share exchange agreement. For more details, please see “Current Operations” disclosure above.

About ByoPlanet:

Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
Press Release | 05/19/2023
ATHENS, GA / ACCESSWIRE / May 19, 2023 / ByoPlanet, a leading provider of advanced disinfection solutions and a wholly owned subsidiary of Plandai Biotechnology Inc. (the "Company") (OTC PINK:PLPL), is excited to announce the establishment of a comprehensive one-year distribution agreement with Merck Animal Health, a global leader in animal health solutions and a division of Merck & Co., to distribute Merck Animal Health's Armatrex antimicrobial solution to the $36 billion animal health market.

Plandai Biotechnology, Friday, May 19, 2023, Press release picture
This strategic collaboration between ByoPlanet and Merck Animal Health aims to leverage the strengths of both companies to deliver advanced antimicrobial solutions to customers across the animal health marketplace, including the commercial and companion animal sectors. ByoPlanet's extensive reach and expertise in the disinfection industry combined with Merck Animal Health's reputation for excellence in animal health will provide customers with unparalleled access to cutting-edge solutions.

Armatrex, developed by Merck Animal Health, is an antimicrobial chemistry specifically designed for the animal health market that bonds to the substrates and creates a powerful bacteriostatic finish. It offers a comprehensive and efficient solution to combat the spread of harmful pathogens, ensuring the well-being and safety of animals. By incorporating Armatrex into their hygiene protocols, customers can maintain a healthier environment and protect animals from potential diseases.

"We are excited about this partnership with Merck Animal Health," said Rick O'Shea, founder of ByoPlanet and CEO of Plandai Biotechnology. "By joining forces with an established global leader, we can expand our offerings to the animal health market and further solidify our position as an emerging force in the advanced disinfectant solutions market. This collaboration underscores our commitment to innovation and our dedication to providing our customers with the most effective products available."

Under the terms of the agreement, ByoPlanet will be responsible for the distribution and marketing of Armatrex to customers in the animal health industry. ByoPlanet's extensive customer base and network of industry relationships will facilitate seamless access to Armatrex for animal health professionals, veterinarians, and other stakeholders in the commercial and companion animal sectors. ByoPlanet management believes this collaboration will enhance the availability and utilization of Armatrex across the animal health market.

Both ByoPlanet and Merck Animal Health are confident that this distribution agreement will strengthen their positions in the animal health market and drive innovation in antimicrobial solutions. By working together, the two companies aim to enhance animal health, improve productivity, and foster sustainable practices across the industry.

About ByoPlanet
ByoPlanet is a leader in disinfection solutions, providing innovative technologies and services that improve health outcomes in a variety of settings. With a focus on providing superior disinfection and infection control solutions, ByoPlanet is committed to working with its partners to develop customized solutions that meet their unique needs. ByoPlanet's disinfection solutions are trusted by businesses and organizations around the world, including animal health, hospitals, education, and government agencies.

About Merck Animal Health
Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of Merck. Through its commitment to The Science of Healthier Animals®, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com.

My comment

We have not received anything about the above deal. I only added this for point of interest. Remember the restricted share increase last Feb is a big deal and, in my opinion, they will hold off on any talk of a R/S because they would never have raised the share structure only to R/S on a near-term action. This would seem out of the ordinary and the Nevada SOS would never allow an increase just to in the near-term to do a Reverse Split.

I strongly believe the increase is asset based and a huge deal is pending. Forget the Sushi catering business, that isn't happening.

Have a good day.
varok

[Jaxxm]

Agree, their profile info updated.. https://www.otcmarkets.com/stock/PLPL/profile

[crazy horse 0]

That is some Great Info on PLPL

Jaxxm, interesting X (Twitter) PLPL possible DD...

I have not made the time to verify any of this, but I had a friend of mine send me this as some interesting DD for PLPL to consider courtesy of Due Diligence Virtuoso, Aquahoya, and Masterpicks. It looks pretty good and is very interesting at the very least...

PLPL Posts
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174280903